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It is tempting to regard the problem ofinvestiga-
tion of health hazards associated with toxic chemi-
cal wastes as almost insoluble at present. Expo-
sures are poorly defined, disease patterns are not
well identified, the relation of effects in other
biological systems to illness in man is not under-
stood. Neither the "dose" nor the response has
been established and certainly not quantitatively.
Pessimism can be augmented with the proposition
that generalizations are inappropriate.
Although analogies canbedrawn amongwaste sites, chem-
ical, geological, ormedical generalizations not based on de-
tailed site-specific analyses should always be considered
unreliable (1).
It would be highly desirable ifit were possible to
secure analyses of every dump site and all details
and all combinations over time. When the biochem-
ists and the analytical chemists complete their
work, we would then call in the hydrologists to
provide patterns for us.
That will be an ideal world. But I am reminded,
for example, that Japanese clinicians knew some-
thing was wrong at Minamata Bay long before we
were able to measure methylmercury, and I think
that Dr. Epstein in London worked at least a dozen
years after Burkett, to find the Epstein-Barr virus
anditspossiblerelationshiptolymphomasdescribed
in East Africa. I am reminded that long before we
knew of nickel carcinogenicity a small town practi-
tionerin South Wales identified the hazard. He saw
a patient with sinus cancer, and saw a second one
three months later. He was struck by the fact that
both patients worked inthe local nickel smelter. He
thought it perhaps too much of a coincidence for
such a rare tumor to occur randomly in two nickel
smelter workers and proposed an etiological associ-
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ation. We still don't know exactly what it is in
nickel smelters that produces sinus or lung cancer,
but we know that it occurs. It is only in the last half
dozen years that Blumberg and others have begun
to clarify the relationship ofhepatitis B virus to the
extraordinary incidence oflivercancer in China and
Hong Kong and South East Asia, East Africa,
India.
Thus, epidemiologicalhunches have turned outto
be very useful. However, by and large it has been
planned epidemiological studies that have provided
the best information concerning environmenl haz-
ards. I am not sure we all appreciate how recent
this is. We assume (correctly) that we can investi-
gate the disease potential ofenvironmental contam-
ination, that it should be studied, that exogenous
agents can produce disease. But such confidence,
such acceptance, is rather new. How recent? Rich-
ard Doll writes (2):
In 1952 ... manypeoplestillbelieved that cancerwas ade-
generative processinextricablyconfounded withaging, that
mostcancerswere, inconsequence, unavoidable.... Sixteen
yearslater ... itwasgenerallyaccepted thatmost cancers
were attributable to extrinsic causes and that at least 4 out
of 5 were preventable....
Those 16 years were very productive. Epidemio-
logical methods were developed that gave us both
valuable data and understanding.
We are now going to have to go beyond that,
however. Eitherwe are goingto have tochange the
toxic chemical waste dump sites or we are going to
have to change epidemiology. And we can. We can
consider approaches such as sero-epidemiology,
biochemicalepidemiology, epidemiological immuno-
toxicology. These are areas I believe we will be
investigating in the next years. Concomitantly, I
amnotsurethatwehavefullyutilizedtheapproaches
which in those 16 years gave us our understanding.
They were in considerable part in two areas, the
first, beinglarge-scale prospective population stud-106 I. J. SELIKOFF
ies. The classic ones, of course, were those at the
American Cancer Society by Hammond and his
colleagues and Doll and his colleagues in Britain;
the first of over a million people in the United
States and the second of British doctors. These
were prospective, with well-defined large popula-
tions. The second approach was to study the
experience of heavily exposed groups, generally
occupationally exposed, to determine what the
biological endpoints might be, and to obtain some
sense of dose-response relatnships, so that at least
an effort at extrapolation could be made. I suspect
that exploitation of what those 16 years showed to
be effective might now very well be in order.
The first two papers for this session will review
how we might apply our proven methodology. I am
not sure that the designs can be worked out. I am
not sure that it will be done with ease, but at least
we can attempt to utilize what has been demon-
strated to be effective. The first paper will examine
the question whether it is possible to obtain direct
epidemiologic evidence of effects of chemical con-
tamination ofpublic water supplies. Dr. Hammond
ofMount Sinai and our Chinese colleagues from the
Peking Institute of Cancer Research in China (Dr.
You and Dr. Wang) have been studying this ques-
tion for the last year. Dr. Lilis will review the
potential of the second approach-study of an
occupational group intimately working with toxic
chemical wastes. We will approximate the ideal
that Dr. Landrigan correctly addressed. The expo-
sures will be uniquely monitored; there will be
continuinganalysis ofall toxic wastes and recurrent
biological monitoring ofthe work force of400 to 500
people exposed to these known toxic chemicals.
An example of new approaches to biological
monitoringwillconclude these contributions, as Dr.
Thomas Clarkson reviews an advance in the inves-
tigation of low-level environmental health effects
from cadmium, lead, and mercury.
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